Apollo Hospitals Enterprise stock
Price history
+23.94% over the period1 year: from ₹7,423.00 (November 20, 2025) to ₹9,200.00 (November 20, 2026), +23.94%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | ₹9,200.00 |
| October 30, 2026 | ₹8,448.00 |
| September 30, 2026 | ₹8,165.50 |
| August 31, 2026 | ₹8,898.50 |
| July 31, 2026 | ₹8,957.00 |
| June 30, 2026 | ₹8,682.00 |
| May 29, 2026 | ₹8,176.50 |
| April 30, 2026 | ₹7,636.50 |
| March 30, 2026 | ₹7,419.00 |
| February 27, 2026 | ₹7,821.50 |
| January 30, 2026 | ₹6,960.50 |
| December 31, 2025 | ₹7,042.50 |
| November 28, 2025 | ₹7,335.50 |
| November 20, 2025 | ₹7,423.00 |
At a glance
The company
Operates a network of hospitals and healthcare facilities providing primary, secondary, tertiary and specialty medical services across India
Latest results
Quarter to September 30, 2026 · EPS ₹43.70 (estimate ₹43.49)
TickerLandia's take on Apollo Hospitals Enterprise
- Priced as usual relative to earnings: P/E on the latest fiscal year 68 vs a median of 72 over its last 10 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 59 vs 29 (+102%) in a group of 11.
- Strong point: Growth (82/100 in its group). Weak point: Dividend (46/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−0.89% from the 52-week high
Analysts · 30 analysts
Average target₹9,970.60+8.38% vs. price
Buy 27 · Hold 3 · Sell 0 · Strong buy
TickerLandia Fingerprint: Apollo Hospitals Enterprise
Compared with similar companies: very high price, very high growth, and very low risk.
Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Pricevery high89
How much it costs relative to what it produces.
Metric Value Position in group Price/sales 4.75 76 P/E (trailing 12 months) 58.8 92 Forward P/E 42.0 97 EV/EBITDA 35.1 87 Price/book 12.5 91 Profitabilityhigh62
How much it earns on revenue and capital.
Metric Value Position in group Net margin 8.1% 55 ROE 22.5% 75 ROA 9.1% 87 Gross margin 35.5% 50 Operating margin 12.1% 45 Earnings stabilityhigh67
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.2% 76 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 58 Growthvery high82
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +14.94% 71 Revenue growth (year over year) +20.80% 97 Earnings growth (year over year) +31.90% 76 Financial strengthhigh64
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 1.12 55 Net debt/EBITDAcounts in reverse: lower means more financial strength 2.07 66 Interest coverage 8.15 66 Debt/equitycounts in reverse: lower means more financial strength 0.73 69 Dividendaverage46
How much it returns to shareholders, and for how long.
Metric Value Position in group Dividend yield 0.2% 21 Consecutive dividend years at least 25 years 86 Payout ratio 12.8% 32 Market momentumstrong80
How the stock has moved compared with the market.
Metric Value Position in group Distance from 200-day average +11.60% 85 1-year return +23.94% 74 Riskvery low20
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 16.2% 8 Volatility (60 days) 29.9% 32
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Apollo Hospitals Enterprise is priced as in the past and pricier than similar companies
On the latest fiscal year's earnings (2026), Apollo Hospitals Enterprise's P/E today is 68.2, in line with the median of its last 10 fiscal years (71.6; between 34.8 and 270.3 from 2017 to 2026). Apollo Hospitals Enterprise's P/E (trailing 12 months): 58.8, +102% against the median of a group of 11 similar companies (29.1).
Compared with 11 similar companies
| Metric | Apollo Hospitals Enterprise | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 58.8 | High | |
| Forward P/E | 42.0 | High | |
| Operating margin | 12.1% | Middle | |
| ROE | 22.5% | High | |
| Debt/equity | 0.73 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Apollo Hospitals Enterprise. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
₹76.15B
Latest quarter · Q3 2026
Net income
₹6.3B
Latest quarter · Q3 2026
Quarterly net margin
8.3%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- ₹1.32T
- P/E
- 58.8
- EPS
- ₹156.39
- Volume
- 1.41M
- Daily trading
- €46.28M
- Dividend yield
- 0.22%
- Last ex-dividend on August 14, 2026
How Apollo Hospitals Enterprise is changing
All resultsRevenue grew 19.0% a year on average over the last 5 years
Operating margin rose from 8.7% to 11.5%
Less cash than profit: free cash flow equal to 49% of net income
Returns
Apollo Hospitals Enterprise returns with dividends
₹1,000 invested in Apollo Hospitals Enterprise 5 years ago, on November 22, 2021, would be worth ₹1,721 today with dividends reinvested: +72.06% in total, +11.48% per year. On price alone it would be ₹1,698 (+69.76%).
| Period | Apollo Hospitals Enterprise | ₹1,000 becomes |
|---|---|---|
| 1 month | +21.05% | ₹1,211 |
| 6 months | +13.88% | ₹1,139 |
| Year to date | +30.64% | ₹1,306 |
| 1 year | +24.24% | ₹1,242 |
| 3 years | +69.34% | ₹1,693 |
| 5 years | +72.06% | ₹1,721 |
| 10 years | +727.29% | ₹8,273 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Apollo Hospitals Enterprise: technical analysis
Apollo Hospitals Enterprise is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is at its all-time closing high.
- Trend
- Upward
- RSI (14 sessions)
- 71
- Above 70: a strong rise in a short time
- vs 200-session average
- +11.60%
Active signals
New 52-week high.
Close above the high of the previous 55 sessions.
RSI above 70: the stock has risen a lot in a short time.
Trading on November 20, 2026 was 2.8 times the 20-session average.
Support and resistance
Price areas where Apollo Hospitals Enterprise has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price₹9,200.00
- Support₹9,001.42−2.16%6 touches, last on September 23, 2026
- Support₹8,661.33−5.86%6 touches, last on November 5, 2026
- Support₹8,475.25−7.88%2 touches, last on August 12, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 29.9%
- Largest fall in the last year
- −16.20%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Apollo Hospitals Enterprise: seasonality
Average monthly price change over 25 years
Over the last 25 years, the strongest month for Apollo Hospitals Enterprise has been November: +4.36% on average, positive in 15 years out of 24. The weakest has been March: −1.52% on average, positive in 13 years out of 24.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.62% | +1.62% | 14 of 24 |
| February | +1.96% | +0.07% | 12 of 24 |
| March | −1.52% | +0.89% | 13 of 24 |
| April | +1.87% | +0.54% | 13 of 24 |
| May | +2.25% | −0.38% | 12 of 24 |
| June | +4.36% | +5.25% | 17 of 24 |
| July | +3.26% | +2.62% | 15 of 24 |
| August | +2.49% | +0.49% | 14 of 25 |
| September | +2.29% | +1.40% | 14 of 25 |
| October | −0.14% | −0.47% | 10 of 25 |
| November | +4.36% | +3.63% | 15 of 24 |
| December | +3.05% | +0.58% | 13 of 24 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Apollo Hospitals Enterprise and its competitors
Apollo Hospitals Enterprise Limited operates on a scale measured in both revenue and workforce: 44,008 employees and INR 252.3 billion in revenue in the fiscal year ended March 2026. The group, together with its subsidiaries, provides healthcare services across India through hospitals, primary care clinics, diagnostic centers, pharmacies, dental and dialysis facilities, and specialty centers for cardiac sciences, oncology, neurosciences, orthopedics, organ transplantation and robotic surgery.
- Headquarters
- Chennai, India
- Employees
- 44,008
- Founded
- 1979
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Apollo Hospitals EnterpriseAPOLLOHOSP | $14.27B | 12.1% | 58.8 | +13.88% |
| Aier Eye Hospital Group300015 | $12.44B | 21.8% | 34.4 | −5.49% |
| Max Healthcare InstituteMAXHEALTH | $9.95B | 21.4% | 67.0 | +0.49% |
| Ramsay Health CareRHC | $8.37B | 5.9% | 40.0 | +40.77% |
| Fortis HealthcareFORTIS | $6.47B | 17.1% | 56.8 | −15.35% |
| Encompass HealthEHC | $13.11B | 18.4% | 21.4 | +26.10% |
Same industry or related industries, similar size. Compare Apollo Hospitals Enterprise with its competitors · Full profile
